Global Live Attenuated Vaccine Industry Research Report 2020, Forecast to 2025

August 2020 | 104 pages | ID: G7841CE429E5EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Live Attenuated Vaccine market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Live Attenuated Vaccine is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Live Attenuated Vaccine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Live Attenuated Vaccine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Live Attenuated Vaccine market are discussed.

The market is segmented by types:

• Bacterial
• Viral

It can be also divided by applications:

• Hospitals
• Clinics
• Research Institutes
• Others

And this report covers the historical situation, present status and the future prospects of the global Live Attenuated Vaccine market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• GlaxoSmithKline
• Serum Institute Of India
• Astellas Pharma
• Merck
• Sanofi
• Pfizer
• CSL
• Johnson & Johnson

Report Includes:

• xx data tables and xx additional tables
• An overview of global Live Attenuated Vaccine market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Live Attenuated Vaccine market
• Profiles of major players in the industry, including GlaxoSmithKline, Serum Institute Of India, Astellas Pharma, Merck, Sanofi.....

Research Objectives

• To study and analyze the global Live Attenuated Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Live Attenuated Vaccine market by identifying its various subsegments.
• Focuses on the key global Live Attenuated Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Live Attenuated Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Live Attenuated Vaccine submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Live Attenuated Vaccine Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Live Attenuated Vaccine Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 LIVE ATTENUATED VACCINE INDUSTRY OVERVIEW

2.1 Global Live Attenuated Vaccine Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Live Attenuated Vaccine Global Import Market Analysis
  2.1.2 Live Attenuated Vaccine Global Export Market Analysis
  2.1.3 Live Attenuated Vaccine Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Bacterial
  2.2.2 Viral
2.3 Market Analysis by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Research Institutes
  2.3.4 Others
2.4 Global Live Attenuated Vaccine Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Live Attenuated Vaccine Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Live Attenuated Vaccine Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Live Attenuated Vaccine Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Live Attenuated Vaccine Manufacturer Market Share
  2.4.5 Top 10 Live Attenuated Vaccine Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Live Attenuated Vaccine Market
  2.4.7 Key Manufacturers Live Attenuated Vaccine Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Live Attenuated Vaccine Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Live Attenuated Vaccine Industry Impact
  2.7.1 How the Covid-19 is Affecting the Live Attenuated Vaccine Industry
  2.7.2 Live Attenuated Vaccine Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Live Attenuated Vaccine Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Live Attenuated Vaccine Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Live Attenuated Vaccine Sales Market Share by Region
4.2 Global Live Attenuated Vaccine Revenue Market Share by Region (2015-2019)
4.3 Global Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Live Attenuated Vaccine Market Size Detail
  4.4.1 North America Live Attenuated Vaccine Sales Growth Rate (2015-2020)
  4.4.2 North America Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Live Attenuated Vaccine Market Size Detail
  4.5.1 Europe Live Attenuated Vaccine Sales Growth Rate (2015-2020)
  4.5.2 Europe Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Live Attenuated Vaccine Market Size Detail
  4.6.1 Japan Live Attenuated Vaccine Sales Growth Rate (2015-2020)
  4.6.2 Japan Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Live Attenuated Vaccine Market Size Detail
  4.7.1 China Live Attenuated Vaccine Sales Growth Rate (2015-2020)
  4.7.2 China Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL LIVE ATTENUATED VACCINE MARKET SEGMENT BY TYPE

5.1 Global Live Attenuated Vaccine Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Live Attenuated Vaccine Sales and Market Share by Type (2015-2020)
  5.1.2 Global Live Attenuated Vaccine Revenue and Market Share by Type (2015-2020)
5.2 Bacterial Sales Growth Rate and Price
  5.2.1 Global Bacterial Sales Growth Rate (2015-2020)
  5.2.2 Global Bacterial Price (2015-2020)
5.3 Viral Sales Growth Rate and Price
  5.3.1 Global Viral Sales Growth Rate (2015-2020)
  5.3.2 Global Viral Price (2015-2020)

6 GLOBAL LIVE ATTENUATED VACCINE MARKET SEGMENT BY APPLICATION

6.1 Global Live Attenuated VaccineSales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Clinics Sales Growth Rate (2015-2020)
6.4 Research Institutes Sales Growth Rate (2015-2020)
6.5 Others Sales Growth Rate (2015-2020)

7 GLOBAL LIVE ATTENUATED VACCINE MARKET FORECAST

7.1 Global Live Attenuated Vaccine Sales, Revenue Forecast
  7.1.1 Global Live Attenuated Vaccine Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Live Attenuated Vaccine Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Live Attenuated Vaccine Price and Trend Forecast (2020-2025)
7.2 Global Live Attenuated Vaccine Sales Forecast by Region (2020-2025)
  7.2.1 North America Live Attenuated Vaccine Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Live Attenuated Vaccine Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Live Attenuated Vaccine Production, Revenue Forecast (2020-2025)
  7.2.4 China Live Attenuated Vaccine Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF LIVE ATTENUATED VACCINE INDUSTRY KEY MANUFACTURERS

8.1 GlaxoSmithKline
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 GlaxoSmithKline Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 GlaxoSmithKline News
8.2 Serum Institute Of India
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Serum Institute Of India Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Serum Institute Of India News
8.3 Astellas Pharma
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Astellas Pharma Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Astellas Pharma News
8.4 Merck
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Merck Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Merck News
8.5 Sanofi
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Sanofi Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Sanofi News
8.6 Pfizer
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Pfizer Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Pfizer News
8.7 CSL
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 CSL Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 CSL News
8.8 Johnson & Johnson
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Johnson & Johnson Live Attenuated Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Johnson & Johnson News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Live Attenuated Vaccine Picture
Figure Research Programs/Design for This Report
Figure Global Live Attenuated Vaccine Market by Regions (2019)
Table Global Market Live Attenuated Vaccine Comparison by Regions (M USD) 2019-2025
Table Global Live Attenuated Vaccine Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Live Attenuated Vaccine by Type in 2019
Figure Bacterial Picture
Figure Viral Picture
Table Global Live Attenuated Vaccine Sales by Application (2019-2025)
Figure Global Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Institutes Picture
Figure Others Picture
Table Global Live Attenuated Vaccine Sales by Manufacturer (2018-2020)
Figure Global Live Attenuated Vaccine Sales Market Share by Manufacturer in 2019
Table Global Live Attenuated Vaccine Revenue by Manufacturer (2018-2020)
Figure Global Live Attenuated Vaccine Revenue Market Share by Manufacturer in 2019
Table Global Live Attenuated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Live Attenuated Vaccine Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Live Attenuated Vaccine Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Live Attenuated Vaccine Market
Table Key Manufacturers Live Attenuated Vaccine Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Live Attenuated Vaccine Sales (K Units) by Region (2015-2020)
Table Global Live Attenuated Vaccine Sales Market Share by Region (2015-2019)
Figure Global Live Attenuated Vaccine Sales Market Share by Region (2015-2019)
Figure Global Live Attenuated Vaccine Sales Market Share by Region in 2018
Table Global Live Attenuated Vaccine Revenue (Million US$) by Region (2015-2020)
Table Global Live Attenuated Vaccine Revenue Market Share by Region (2015-2020)
Figure Global Live Attenuated Vaccine Revenue Market Share by Region (2015-2020)
Figure Global Live Attenuated Vaccine Revenue Market Share by Region in 2019
Table Global Live Attenuated Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Live Attenuated Vaccine Sales (K Units) Growth Rate (2015-2020)
Table North America Live Attenuated Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Live Attenuated Vaccine Sales (K Units) Growth Rate (2015-2020)
Table Europe Live Attenuated Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Live Attenuated Vaccine Sales (K Units) Growth Rate (2015-2020)
Table Japan Live Attenuated Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Live Attenuated Vaccine Sales (K Units) Growth Rate (2015-2020)
Table China Live Attenuated Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Live Attenuated Vaccine Sales by Type (2015-2020)
Table Global Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Figure Global Live Attenuated Vaccine Sales Market Share by Type in 2019
Table Global Live Attenuated Vaccine Revenue by Type (2015-2020)
Table Global Live Attenuated Vaccine Revenue Market Share by Type (2015-2020)
Figure Global Live Attenuated Vaccine Revenue Market Share by Type in 2019
Figure Global Bacterial Sales Growth Rate (2015-2020)
Figure Global Bacterial Price (2015-2020)
Figure Global Viral Sales Growth Rate (2015-2020)
Figure Global Viral Price (2015-2020)
Table Global Live Attenuated Vaccine Sales by Application (2015-2020)
Table Global Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Figure Global Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Clinics Sales Growth Rate (2015-2020)
Figure Global Research Institutes Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Live Attenuated Vaccine Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Live Attenuated Vaccine Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Live Attenuated Vaccine Price and Trend Forecast (2020-2025)
Table Global Live Attenuated Vaccine Sales (K Units) Forecast by Region (2020-2025)
Figure Global Live Attenuated Vaccine Production Market Share Forecast by Region (2020-2025)
Figure North America Live Attenuated Vaccine Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Live Attenuated Vaccine Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Live Attenuated Vaccine Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Live Attenuated Vaccine Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Live Attenuated Vaccine Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Live Attenuated Vaccine Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Live Attenuated Vaccine Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Live Attenuated Vaccine Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table GlaxoSmithKline Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of GlaxoSmithKline
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure GlaxoSmithKline Live Attenuated Vaccine Market Share (2018-2020)
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Serum Institute Of India Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Serum Institute Of India
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Serum Institute Of India Live Attenuated Vaccine Market Share (2018-2020)
Table Serum Institute Of India Main Business
Table Serum Institute Of India Recent Development
Table Astellas Pharma Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Astellas Pharma
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Astellas Pharma Live Attenuated Vaccine Market Share (2018-2020)
Table Astellas Pharma Main Business
Table Astellas Pharma Recent Development
Table Merck Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Merck
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck Live Attenuated Vaccine Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Sanofi Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Sanofi
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Live Attenuated Vaccine Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Pfizer Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Pfizer
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Live Attenuated Vaccine Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table CSL Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of CSL
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSL Live Attenuated Vaccine Market Share (2018-2020)
Table CSL Main Business
Table CSL Recent Development
Table Johnson & Johnson Company Profile
Figure Live Attenuated Vaccine Product Picture and Specifications of Johnson & Johnson
Table Live Attenuated Vaccine Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Live Attenuated Vaccine Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table of Appendix